24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Molecular and biochemical basis <strong>of</strong> disease<br />

tions) in the GSK3beta gene could partially underlie the susceptibility<br />

to mood disorders, just as much to unipolar major depression as to<br />

bipolar disorder . We performed a genetic case-control study including<br />

440 screened control subjects and 445 patients with MD (257 Unipolar<br />

Major Depressive Disorder, 188 Bipolar Disorder) . First, we selected<br />

a set <strong>of</strong> 11 TagSNPs polymorphisms representative <strong>of</strong> the patterns <strong>of</strong><br />

common variation identified in <strong>European</strong> population in the genomic<br />

region containing the GSK3beta gene and genotyped them using SN-<br />

Plex Genotyping System . Moreover, we are replicating the experiment<br />

<strong>of</strong> Lachman et al . in our Spanish sample <strong>of</strong> MD patients . They found<br />

a statistical significant increased number <strong>of</strong> gains in a CNV partially<br />

overlapping GSK3beta in bipolar patients compared with control individuals<br />

. All the results were analyzed using SNPassoc package, from<br />

R s<strong>of</strong>tware . Regarding TagSNPs analyses, nominal associations were<br />

found once stratified by polarity, even though they did not remain significant<br />

after correction for multiple comparisons. Overall, although genetic<br />

variants in GSK3beta gene might be a contributing factor to the<br />

development <strong>of</strong> mood disorders, further studies in larger samples are<br />

needed to obtain more conclusive results .<br />

P06.122<br />

Study <strong>of</strong> an association <strong>of</strong> deletion/insertion polymorphisms<br />

<strong>of</strong> GSTM and GSTT genes with a risk <strong>of</strong> development <strong>of</strong><br />

endometriosis<br />

E. Kamenec1 , O. A. Schagina1 , L. F. Kurilo1 , L. M. Michaleva2 , A. V. Polyakov1 ;<br />

1 2 Reseach Centre for Medical <strong>Genetics</strong>, Moscow, Russian Federation, Institution<br />

<strong>of</strong> <strong>Human</strong> Morphology RAMN, Moscow, Russian Federation.<br />

Endometriosis is a common disease defined as a growth <strong>of</strong> endometrial<br />

tissue outside the uterine cavity that <strong>of</strong>ten results a vast array <strong>of</strong> gynaecological<br />

problems including dysmenorrhoea, pelvic pain, infertility .<br />

Endometriosis is regarded as one <strong>of</strong> the multifactorial diseases caused<br />

by an interaction between the environment and multiple genes .<br />

Glutathione-S-transferases (GSTs) are enzymes involved in the phase<br />

II detoxification process <strong>of</strong> xenobiotics including carcinogens and mutagens<br />

. Gene polymorphisms <strong>of</strong> members <strong>of</strong> the GSTs family might<br />

impair detoxification function and increase the risk <strong>of</strong> the disorder. The<br />

present study was carried out to investigate if deletion/insertion polymorphisms<br />

<strong>of</strong> GSTM1, GSTT1 and there combination are useful markers<br />

for predicting endometriosis susceptibility .<br />

DNA was extracted from blood <strong>of</strong> 40 patients with reliable diagnosis <strong>of</strong><br />

endometriosis and 50 healthy women (control group) . DNA samples<br />

were amplified by polymerase chain reaction and detected by electrophoresis<br />

. The relative frequencies <strong>of</strong> the GSTM1 wild/null and the<br />

GSTT1 wild/null genotypes between both groups were compared .<br />

The proportion <strong>of</strong> individuals with GSTM1 null mutation was 45% in<br />

the endometriosis group and 30% in the control group (P > 0 .05), the<br />

proportions <strong>of</strong> GSTT1 wild/null allels in both groups were 22 .5%/18%<br />

accordingly (P > 0 .05) . The proportions <strong>of</strong> GSTM1(null/null) +<br />

GSTT1(null/null) genotype were 12 .5%/2% (P > 0 .05) . The distribution<br />

<strong>of</strong> the polymorphisms and there combination was not significantly different<br />

between the two groups . These results suggest that the GSTM1<br />

and the GSTT1 null mutations aren’t associated with a risk <strong>of</strong> the development<br />

<strong>of</strong> endometriosis in Russian women .<br />

P06.123<br />

Risk Factors <strong>of</strong> inhibitors Development in Haemophilia Patients<br />

M. Mihailov, M. Serban, D. Savescu, S. Arghirescu, C. Petrescu, M. Puiu;<br />

University <strong>of</strong> Medicine and Pharmacy “Victor Babes” Timisoara, Romania, Timisoara,<br />

Romania.<br />

Introduction . FVIII inhibitors appearance in haemophiliacs is related to<br />

several factors, like substitution with native plasma products, frequent<br />

changing <strong>of</strong> FVIII concentrates, high rate <strong>of</strong> HBV and HCV infection,<br />

pseudotumours and other massive muscular haematomas, etc .<br />

Objective . Starting from particularities <strong>of</strong> haemophilia treatment in our<br />

country, we evaluated the variables impact on inhibitors development .<br />

We assessed frequency and inhibitors titer, in correlation with risk factors<br />

.<br />

Material and method: retrospective single center study based on 219<br />

hemophilia patients registered and treated in the IIIrd Pediatric Clinic<br />

Timisoara, using Bethesda assay. We evaluated the influence <strong>of</strong> some<br />

parameters on frequency and inhibitors titer: haemophilia severity,<br />

gene mutations, family history, type <strong>of</strong> substitutive product used, hepatitis<br />

C or B infection, Interferon alpha therapy, surgical interventions,<br />

and bolus vs . intravenous infusion <strong>of</strong> FVIII .<br />

Results . Between January 1997- 2002, inhibitors frequency was 47 .5%,<br />

whereas after January 2002 only 19 .19% <strong>of</strong> patients had inhibitors due<br />

to reactants and methodology change . The majority <strong>of</strong> inhibitors were<br />

in severe haemophilia (78 .95%), 15 <strong>of</strong> these patients being positive for<br />

intron 22 inversion .<br />

Family history and exposure to FVIII were important risk factors <strong>of</strong> inhibitors<br />

development . Hepatitis C or B infection, Interferon alpha therapy,<br />

surgical interventions and intravenous infusion <strong>of</strong> FVIII haven’t<br />

been significantly correlated with inhibitors’ development.<br />

Conclusions . In our patients, we found only the following risk factors for<br />

inhibitors development: exposure to FVIII, type <strong>of</strong> FVIII gene mutations<br />

and familial predisposition . Accuracy <strong>of</strong> technique and experience <strong>of</strong><br />

laboratory technician is decisive for inhibitor evaluation .<br />

P06.124<br />

Association <strong>of</strong> the iL4R single-nucleotide polymorphism s411L<br />

with Hand Osteoarthritis<br />

M. Vargiolu1 , T. Silvestri2 , E. Bonora1 , P. Dolzani2 , L. Punzi3 , A. Fioravanti4 , G.<br />

Romeo1 , R. Meliconi2,5 ;<br />

1U.O. Genetica Medica, Policlinico S. Orsola-Malpighi via Massarenti, Bologna,<br />

Italy, 2Laboratorio di Immunologia e Genetica, Istituti Ortopedici Rizzoli,<br />

Bologna, Italy, 3Rheumatology Unit, University <strong>of</strong> Padova, Italy, Padova, Italy,<br />

4 5 Rheumatology Unit, Policlinico “Le Scotte”, Siena, Italy, Rheumatology Unit,<br />

Istituti Ortopedici Rizzoli, Bologna, Italy.<br />

Primary osteoarthritis (OA) is a common late-onset arthritis that demonstrates<br />

a complex mode <strong>of</strong> transmittance with both joint-site and<br />

gender-specific heterogeneity. In OA anti-inflammatory and anabolic<br />

cytokines which are usually responsible for the control <strong>of</strong> cartilage<br />

homeostasis are altered or inadequate . Hitherto, functional study had<br />

been mainly focused on the IL13/IL-4/IL-4R system which has a strong<br />

chondroprotective role and it is reasonable to speculate that polymorphism<br />

within these genes may be risk factors for OA . We therefore<br />

investigated polymorphisms in these genes as potential OA susceptibility<br />

loci by genotyping fifteen SNPs using TaqMan® Technology in<br />

413 patients (26 male, 387 female) with hand OA and 326 healthy<br />

controls (14 male, 312 female) .Although the majority <strong>of</strong> these SNPs<br />

had already shown an association with OA in previous studies, in our<br />

case-control study only one SNP (dbSNP rs1805013) was associated<br />

with P-values <strong>of</strong> 0 .0125 . This association was attributable to an increased<br />

frequency in the probands <strong>of</strong> the minor T allele regardless <strong>of</strong><br />

gender and disease severity . This SNP results in the substitution <strong>of</strong> a<br />

serine with a leucine in the codon 411 <strong>of</strong> IL4R and consequently <strong>of</strong> an<br />

aliphatic hydrophobic residue for a polar hydrophilic one, a change that<br />

could have effects on protein function . Further functional studies for<br />

the S411L substitutions will clarify the role <strong>of</strong> this SNP on osteoarthritis<br />

predisposition .<br />

P06.125<br />

tmc1 but Not tmc2 is Responsible for Autosomal Recessive<br />

Nonsyndromic Hearing impairment in tunisian Families<br />

A. Tlili 1,2 , I. Ben Rebeh 2 , M. Aifa-Hmani 2 , J. Tlili-Chouchène 1 , H. Dhouib 3 , J.<br />

Moalla 3 , M. Ben Said 2 , I. Lahmar 4 , Z. Benzina 5 , I. Charfedine 3 , N. Driss 4 , A.<br />

Ghorbel 3 , H. Ayadi 2 , S. Masmoudi 2 ;<br />

1 Laboratoire de Génétique Moléculaire Humaine, Sfax, Tunisia, 2 Unité Cibles<br />

pour le Diagnostic et la Thérapie , Centre de Biotechnologie de Sfax, Sfax,<br />

Tunisia, 3 Service d’O.R.L., C.H.U.H. Bourguiba de Sfax, Sfax, Tunisia, 4 Service<br />

d’O.R.L., C.H.U. de Mahdia, Mahdia, Tunisia, 5 Service d’Ophtalmologie, C.H.U.<br />

H. Bourguiba de Sfax, Sfax, Tunisia.<br />

Hereditary nonsyndromic hearing impairment (HI) is extremely heterogeneous<br />

. Mutations <strong>of</strong> the transmembrane channel-like gene 1<br />

(TMC1) have been shown to cause autosomal dominant and recessive<br />

forms <strong>of</strong> nonsyndromic HI linked to the loci DFNA36 and DFNB7/<br />

B11, respectively . TMC1 is 1 member <strong>of</strong> a family <strong>of</strong> 8 genes encoding<br />

transmembrane proteins . In the mouse, MmTmc1 and MmTmc2 are<br />

both members <strong>of</strong> Tmc subfamily A and are highly and almost exclusively<br />

expressed in the cochlea . The restricted expression <strong>of</strong> Tmc2 in<br />

the cochlea and its close phylogenetic relationship to Tmc1 makes it<br />

a candidate gene for nonsyndromic HI . We analyzed 3 microsatellite<br />

markers linked to the TMC1 and TMC2 genes in 85 Tunisian families<br />

with autosomal recessive nonsyndromic HI and without mutations in<br />

the protein-coding region <strong>of</strong> the GJB2 gene . Autozygosity by descent<br />

analysis <strong>of</strong> 2 markers bordering the TMC2 gene allowed us to rule

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!